Hyperthermia therapy uses carefully controlled heat to support the body’s natural defense systems. In integrative oncology, therapeutic heat is used to activate immune signaling, improve circulation, and create metabolic stress that cancer cells are less able to tolerate—while supporting overall physiologic resilience.

Hyperthermia does not replace conventional cancer treatment. At CIOFM, it is used as a supportive therapy within a personalized care plan.

The difference lies in scope and intent.

Whole-body hyperthermia gently raises the body’s core temperature to create a systemic, fever-like immune response. This approach supports immune communication, circulation, detoxification, and nervous system regulation.

Localized hyperthermia focuses heat on a specific area of the body, creating targeted metabolic stress in tissue while keeping the rest of the body at normal temperature.

CIOFM offers both options so care can be tailored to diagnosis, disease location, and overall health status.

Cancer cells are metabolically inflexible and often poorly vascularized, making them more sensitive to heat than healthy cells. Controlled heat can:

• Increase metabolic stress on cancer cells

• Improve immune recognition of abnormal tissue

• Enhance circulation and oxygen delivery

• Support detoxification and tissue repair

Hyperthermia leverages one of the body’s oldest defense mechanisms—fever—without relying on uncontrolled inflammation.

When used appropriately and under medical supervision, hyperthermia is generally well tolerated. Safety depends on:

• Proper patient selection

• Appropriate dosing and timing

• Monitoring during treatment

Not every patient is a candidate, and hyperthermia is not used during every phase of care. At CIOFM, safety and clinical context guide all recommendations.

Hyperthermia is not considered a standalone cancer-killing therapy. Its role is supportive.

It may weaken cancer cells, improve immune response, and enhance the effectiveness of other therapies—but it does not replace chemotherapy, radiation, surgery, or targeted treatments when those are indicated.

CIOFM’s approach focuses on strengthening the terrain in which healing occurs.

In many cases, yes—but timing and coordination matter.

Hyperthermia is sometimes used to:

• Improve circulation and oxygenation

• Enhance tissue responsiveness

• Support recovery and immune resilience

All decisions are made in coordination with a patient’s oncology team when appropriate.

Frequency varies based on:

• Type of hyperthermia (whole-body vs localized)

• Treatment phase

• Overall health and tolerance

• Goals of care

Some patients may use hyperthermia periodically, while others incorporate it more regularly for a defined period.

Experiences vary, but patients commonly describe:

• A deep sense of warmth

• Relaxation or fatigue afterward

• Increased sweating (with whole-body hyperthermia)

Patients are encouraged to hydrate well and communicate any discomfort during sessions so adjustments can be made.

Hyperthermia should feel therapeutic, not extreme. Sessions are adjusted to stay within safe and tolerable ranges. Discomfort is not required for benefit, and overheating is avoided.

Hyperthermia may not be appropriate for individuals with certain cardiovascular conditions, uncontrolled infections, severe dehydration, or other specific medical concerns.

Eligibility is determined through a comprehensive review of medical history and current treatment status.